Bullish & Foolish
Full SSII fundamentals All 466 on the Survival Watch

SSIISS INNOVATIONS INTERNATIONAL, INC.

Is SS Innovations International struggling financially?

Yes, by its own account. SS Innovations International told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Cries for help

  • Reverse stock split

    In addition, among other matters, the Company changed its name to “ SS Innovations International, Inc. ” and implemented a one for ten reverse stock split. The Transaction was accounted for as a recapitalization in accordance with GAAP (the “ Recapitalization ”).

    Form 10-Q, filed 13 May 2026. Read it on SEC.gov

Signs of a way out

Nothing in the filings we have read names a way out.

Sector
Biotech/Pharma
Market cap
$718.4M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 4months

    If the burn speeds up

    Empty by Oct 2026

  • 7months

    If it eases off

    Empty by Jan 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$13.6M

÷

Cash burned over the last 12 months

$31.1M

What SS Innovations International told the SEC

…three months ended March 31, 2026, respectively. In addition, the Company has been dependent on related parties to fund operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited interim condensed consolidated financial statements are issued. On March 6, 2026 (the “ Closing Date ”), the Company completed a…

SS INNOVATIONS INTERNATIONAL, INC., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Cash burn is increasing It is spending 12% more cash per year than it was, so the runway above shortens even if nothing else changes.

Other Biotech/Pharma companies that filed the doubt